Merging decades of expertise into one report
Both the Pharmacy Market Outlook and Budget Impact Projections report have been based on the data-enabled expertise from Vizient – providing forecasting and intelligence resources for healthcare organizations for many years. Now, those publications, combined with other healthcare expense management insights, have come together to create the inaugural Spend Management Outlook.
Inside the report
Your guide to healthcare financial insights
The Spend Management Outlook provides an integrated perspective on the trends, factors and future expenses providers will face across the dimensions of healthcare including:
- Medical and surgical products
- Laboratory
- Indirect spend and purchased services
- Capital equipment solutions
- Pharmacy
- Physician preference items
0.00
%
Projected overall drug price inflation rate for July 1, 2025 – June 30, 2026.
0.00
%
Projected inflation rate for market prices encompassing the healthcare supply chain for July 1, 2025 – June 30, 2026.
Access now
Empower your decision-making with our latest projections and insights
The winter 2025 Spend Management Outlook represents our best estimate of healthcare supply chain market prices between July 1, 2025 and June 30, 2026.
Vizient clients
Enjoy access to companion resources and additional information
A high-level overview and highlights from the Spend Management Outlook.
Includes an overview of the strategic importance of the healthcare landscape and a healthcare enterprise preparedness assessment.
Access the Drug Budget Forecast Report and apply the projections in the Spend Management Outlook to your unique purchasing patterns to develop your budget. This tool is available through Vizient Pharmacy Analytics, accessible through the Pharmacy Portal from your Dashboard.
Find out how to use the report. This guide provides an overview on how to best utilize and optimize the Drug Budget Forecast reporting solution.
Supports cost reduction initiatives by providing price visibility, real-time market data and price benchmarking capability with product advisor support.
Simplifies the complex capital procurement process, increases efficiencies and minimizes risks. This web-based platform offers a comprehensive suite of features designed to elevate and simplify the capital budgeting experience.
Provides the ability to view categorized spend, identify opportunities for standardization, see comparative performance data, and take action by linking opportunities to existing contracts and engaging Vizient sourcing experts to ensure you’re maximizing the full value available.
Anticipated high-impact approvals – Overview of anticipated high-impact approvals over the next year listed by therapeutic area. Includes drug indications and estimated wholesale acquisition costs.
New and noteworthy novel drug approvals – Forecasted timeline for new drug approvals, including route, MOA, indication(s) and noteworthy information.
Price projections and additional details for over 200 product spend categories from Vizient supply contracts.
This monthly brief has three primary sections providing updates on the fundamental factors impacting the cost of goods and services. Each section covers the current market and trends within energy, freight, raw materials and wages.
Join us Wednesday, Jan. 29, at 1 p.m. CT when we will review the insights and projections provided in the inaugural edition of the report.